The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery-Reference-Cited by-同舟云学术

The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery

Published:2022-11-14 Issue:1 Volume:86 Page:57-64
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Chen Meng-Chao,Su Hsuan-Yu,Su Yen-Hao,Huang Kuo-Hung,Fang Wen-Liang,Lin Chii-Wann,Chen Ming-Huang,Chao Yee,Lo Su-Shun,Fen-Yau Li Anna,Wu Chew-Wun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference27 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Sung;CA Cancer J Clin,2021

2. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses.;Shiraishi;Cancer,2019

3. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.;Bilici;Tumour Biol,2015

4. Predictors of timing and patterns of recurrence after curative resection for gastric cancer.;Eom;Dig Surg,2010

5. Characteristics of gastric cancer recurrence five or more years after curative gastrectomy.;Shin;Chin J Cancer Res,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Helicobacter pylori Infection on Survival Outcomes of Patients Undergoing Radical Gastrectomy after Neoadjuvant Chemotherapy: A Multicenter Study in China;2024-06-14

2. Comprehensive genomic profiling aids a diagnosis of uncertain pathology;Taiwanese Journal of Obstetrics and Gynecology;2024-05

3. Front-line chemoimmunotherapy for treating epithelial ovarian cancer: Part II promising results of phase 2 study of paclitaxel-carboplatin-oregovomab regimen;Taiwanese Journal of Obstetrics and Gynecology;2024-01

4. Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer;Annals of Surgical Oncology;2023-11-23

5. Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125;Taiwanese Journal of Obstetrics and Gynecology;2023-11